查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930144

全球牛隻疫苗市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考量因素以及未来预测（2026-2034）

Bovine Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 请询问到货日

价格

牛隻疫苗市场成长因素

全球牛隻疫苗市场在保护牛群健康和确保全球肉类及乳製品品质方面发挥着至关重要的作用。牛用疫苗广泛用于预防严重影响畜牧业生产力和农场经济的传染病，例如口蹄疫、出血性败血症、黑蹄病、布鲁氏菌病、乳腺炎和钝性皮肤病。

根据这份报告，2025年全球牛用疫苗市场价值为39亿美元。预计到2026年，该市场将成长至40.4亿美元，到2034年将达到63.2亿美元，在预测期（2026-2034年）内，复合年增长率（CAGR）为5.76%。这种稳定增长反映了疾病的日益普及、对乳製品和肉类产品需求的增长以及人们对预防性兽医保健意识的提高。

市场驱动因素

推动牛用疫苗市场成长的关键因素之一是畜牧业传染病的日益普及。仅口蹄疫就影响了全球约 77.0% 的牲畜，凸显了广泛接种疫苗的必要性。此外，乳腺炎等疾病给农民带来了沉重的经济负担，导致牲畜提前淘汰和生产力下降。

全球对乳製品和肉类产品的需求不断增长，也进一步加速了疫苗的普及。全球数百万头乳牛用于牛奶生产，因此疾病预防对于维持优质产品和稳定供应至关重要。此外，农民对动物福利和健康保健意识的提高，也推动了疫苗接种率的提高和对牲畜健康管理计画的投资。

市场限制因子

儘管成长前景光明，但由于发展中国家疫苗接种覆盖率有限，市场仍面临挑战。兽医基础设施匮乏、意识薄弱和经济限制阻碍了低收入地区的疫苗普及。每年仍有相当比例的牲畜因传染病而死亡，这凸显了疫苗接种覆盖率的差距。

市场机会

牛疫苗市场蕴藏着巨大的机遇，这主要得益于研发部门致力于开发针对新发和地方性疾病的疫苗。生物技术和免疫学的进步使得开发更具针对性和有效性的疫苗成为可能。新一代疫苗和重组疫苗等创新技术在提高疾病控制的同时，也提升了牛群的生产力。

市场挑战

高昂的研发成本和严格的监管审批流程给市场参与者带来了重大挑战。监管壁垒往往会延长产品研发週期，尤其是对于重组疫苗和新型疫苗而言。这些挑战可能会限制发展中地区获得价格合理的疫苗，并延缓创新解决方案的推广应用。

新兴市场趋势

推动市场发展的关键趋势之一是开发用于牛隻健康的mRNA疫苗。这项技术能够加快疫苗研发速度，更能适应新出现的病原体，并有可能同时针对多种疾病。大型企业之间的策略联盟正在加速先进疫苗平台的商业化，并影响全球兽用疫苗市场格局。

市场区隔分析

依产品类型划分，市场可分为：灭活疫苗、减毒活疫苗、重组疫苗和其他疫苗。灭活疫苗市场占有率最大，这主要归功于其高效性、不断推出的新产品以及获得监管部门的批准。减毒活疫苗也保持相当可观的市场占有率，而重组疫苗由于其成本效益高、品质不断提高，预计将以显着的复合年增长率增长。

依给药途径划分，市场可分为注射剂、口服剂及鼻腔给药剂。注射剂疫苗因其高免疫反应和快速起效而占市场主导地位。鼻腔和口服疫苗因其易于接种且适用于大规模疫苗接种计划而备受关注。

依分销管道划分，兽医院在政府主导的疫苗接种运动和疾病控制计划的支持下占市场主导地位。由于服务可及性提高和兽医数量增加，兽医诊所和药房的市场占有率也呈现稳定成长。

区域展望

截至2025年，北美将主导牛隻疫苗市场，占46.50%的市场占有率，区域市场规模将达到18.1亿美元。健全的监管框架、对动物健康的重视以及大量的研发投入支撑了该地区的优势。

由于人畜共患病的日益普及和政府支持的疫苗接种计划，欧洲预计将保持稳定成长。由于乳製品产量的增加、疾病发病率的上升以及对畜牧业的日益重视，亚太地区预计将实现显着增长。由于政府主导的疫苗接种计画增加，预计拉丁美洲和中东及非洲地区将出现温和成长。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家和地区的牛病概述（2025 年）
  • 主要国家和地区的监管现状（2025 年）
  • 牛病疫苗接种概述
  • 主要公司的新产品发布
  • 主要产业趋势：併购、业务合作等
  • 影响COVID-19 对全球牛隻疫苗市场的影响

第五章 全球牛隻疫苗市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品分类
    • 灭活​​疫苗
    • 减毒活疫苗
    • 重组疫苗
    • 其他
  • 市场分析、洞察与预测：依给药途径
    • 口服
    • 注射
    • 鼻腔给药
  • 市场分析、洞察与预测：依销售管道
    • 兽医院
    • 兽医诊所
    • 药局
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美牛隻疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲牛疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 其他欧洲国家

第八章亚太地区牛隻疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲牛疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东与非洲牛疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会（海湾合作委员会）国家
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 世界市场占有率分析(2025年)
  • 企业简介
    • Elanco
    • HIPRA
    • Boehringer Ingelheim International GmbH
    • Virbac
    • Merck &Co., Inc.
    • Zoetis Services LLC
    • Ceva
    • Indian Immunologicals Ltd.
Product Code: FBI112837

Growth Factors of bovine vaccines Market

The global bovine vaccines market plays a critical role in safeguarding cattle health and ensuring the quality of meat and dairy products worldwide. Bovine vaccines are widely used to prevent infectious diseases such as Foot and Mouth Disease (FMD), hemorrhagic septicemia, black quarter, brucellosis, mastitis, and lumpy skin disease, which significantly affect livestock productivity and farm economics.

According to the report, the global bovine vaccines market size was valued at USD 3.9 billion in 2025. The market is projected to grow to USD 4.04 billion in 2026 and further reach USD 6.32 billion by 2034, registering a compound annual growth rate (CAGR) of 5.76% during the forecast period (2026-2034). This steady growth reflects increasing disease prevalence, rising demand for dairy and meat products, and growing awareness of preventive veterinary care.

Market Drivers

One of the primary factors driving the bovine vaccines market growth is the rising prevalence of infectious livestock diseases. Foot and Mouth Disease alone affects nearly 77.0% of the global livestock population, creating a strong need for widespread immunization. Additionally, diseases such as mastitis impose substantial financial burdens on farmers, leading to premature culling and productivity losses.

The growing global demand for milk and meat further accelerates vaccine adoption. Millions of dairy cows are used globally for milk production, increasing the necessity for disease prevention to maintain yield quality and supply consistency. Moreover, increased farmer awareness regarding animal welfare and preventive healthcare has resulted in higher vaccination rates and investments in livestock health management programs.

Market Restraints

Despite positive growth prospects, the market faces challenges due to limited uptake of immunization in developing countries. Inadequate veterinary infrastructure, low awareness, and economic constraints restrict vaccine penetration in lower-income regions. A significant proportion of preventable livestock deaths still occur annually due to infectious diseases, highlighting the gap in vaccination coverage.

Market Opportunities

The bovine vaccines market offers strong opportunities driven by research and development initiatives focused on launching vaccines for emerging and region-specific diseases. Advances in biotechnology and immunology have enabled the development of more targeted and effective vaccines. Innovations such as next-generation and genetically engineered vaccines are improving disease control while enhancing herd productivity.

Market Challenges

High development costs and stringent regulatory approval processes present key challenges for market players. Regulatory hurdles often extend product development timelines, especially for genetically engineered and novel vaccines. These challenges can limit the availability of affordable vaccines in developing regions and slow the adoption of innovative solutions.

Emerging Market Trends

An important trend shaping the market is the development of mRNA vaccines for bovine health. This technology allows faster vaccine development, adaptability to emerging pathogens, and the potential to target multiple diseases simultaneously. Strategic collaborations among leading companies are accelerating the commercialization of advanced vaccine platforms, influencing global veterinary vaccine trends.

Segmentation Analysis

By product, the market is segmented into inactivated, live attenuated, recombinant, and others. The inactivated vaccines segment holds the largest market share due to higher efficacy, increased product launches, and regulatory approvals. Live attenuated vaccines also maintain a substantial share, while recombinant vaccines are expected to grow at a notable CAGR due to cost-effective production and improved quality.

Based on route of administration, the market includes parenteral, oral, and intranasal vaccines. The parenteral segment dominates owing to high immune response and faster onset of action. Intranasal and oral routes are gaining traction due to ease of administration and suitability for mass vaccination programs.

By distribution channel, veterinary hospitals lead the market, supported by government-led vaccination campaigns and disease control programs. Veterinary clinics and pharmacies are also witnessing steady growth due to improved accessibility and rising veterinary practitioner numbers.

Regional Outlook

North America dominated the bovine vaccines market in 2025, accounting for a 46.50% market share, with a regional market size of USD 1.81 billion. Strong regulatory frameworks, high awareness of animal health, and significant R&D investments support regional dominance.

Europe is expected to grow steadily due to increasing zoonotic disease prevalence and government-backed vaccination initiatives. The Asia Pacific region is projected to register significant growth, driven by expanding dairy production, rising disease incidence, and growing focus on animal husbandry. Latin America and the Middle East & Africa are anticipated to witness moderate growth supported by increasing government vaccination programs.

Competitive Landscape

The market is characterized by the presence of established players with strong product portfolios and active R&D strategies. Key companies include Zoetis Services LLC, Merck & Co., Inc., Elanco, HIPRA, Boehringer Ingelheim International GmbH, Virbac, Ceva, and Indian Immunologicals Ltd. Continuous product launches, regulatory approvals, and strategic collaborations remain central to maintaining competitive positioning.

Conclusion

The global bovine vaccines market demonstrates steady and sustainable growth, supported by the increasing burden of infectious cattle diseases and the rising global demand for safe, high-quality dairy and meat products. Valued at USD 3.9 billion in 2025, the market is expected to reach USD 4.04 billion in 2026 and further expand to USD 6.32 billion by 2034, growing at a CAGR of 5.76% during 2026-2034. Strong adoption of preventive veterinary care, especially in developed regions such as North America, continues to strengthen market expansion.

Advancements in vaccine technologies, including inactivated, recombinant, and emerging mRNA-based vaccines, along with increasing research and development initiatives, are enhancing disease prevention and herd productivity. At the same time, government-led vaccination programs and growing awareness among farmers are improving vaccine uptake across key regions. Although challenges such as high development costs, regulatory hurdles, and limited immunization coverage in developing economies persist, ongoing innovation and strategic collaborations among leading players are expected to sustain market growth and improve global bovine health outcomes over the forecast period.

Segmentation By Product

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Intranasal

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • U.S.
    • Canada
  • Europe (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of Bovine Diseases by Key Countries, By Key Countries/ Region, 2025
  • 4.2. Regulatory Scenario by Key Countries/ Region, 2025
  • 4.3. Overview of Vaccination for Bovine Diseases
  • 4.4. New Product Launches, By Key Players
  • 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.6. Impact of COVID-19 on the Global Bovine Vaccines Market

5. Global Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.2.1. Oral
    • 5.2.2. Parenteral
    • 5.2.3. Intranasal
  • 5.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.3.1. Veterinary Hospitals
    • 5.3.2. Veterinary Clinics
    • 5.3.3. Pharmacies & Drug Stores
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.2.1. Oral
    • 6.2.2. Parenteral
    • 6.2.3. Intranasal
  • 6.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.3.1. Veterinary Hospitals
    • 6.3.2. Veterinary Clinics
    • 6.3.3. Pharmacies & Drug Stores
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.2.1. Oral
    • 7.2.2. Parenteral
    • 7.2.3. Intranasal
  • 7.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.3.1. Veterinary Hospitals
    • 7.3.2. Veterinary Clinics
    • 7.3.3. Pharmacies & Drug Stores
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. Germany
    • 7.4.2. U.K.
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.2.1. Oral
    • 8.2.2. Parenteral
    • 8.2.3. Intranasal
  • 8.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.3.1. Veterinary Hospitals
    • 8.3.2. Veterinary Clinics
    • 8.3.3. Pharmacies & Drug Stores
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.2.1. Oral
    • 9.2.2. Parenteral
    • 9.2.3. Intranasal
  • 9.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.3.1. Veterinary Hospitals
    • 9.3.2. Veterinary Clinics
    • 9.3.3. Pharmacies & Drug Stores
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Bovine Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.2.1. Oral
    • 10.2.2. Parenteral
    • 10.2.3. Intranasal
  • 10.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.3.1. Veterinary Hospitals
    • 10.3.2. Veterinary Clinics
    • 10.3.3. Pharmacies & Drug Stores
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Elanco
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. HIPRA
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Boehringer Ingelheim International GmbH
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Virbac
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Merck & Co., Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Zoetis Services LLC
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Ceva
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Indian Immunologicals Ltd.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2034
  • Table 2: Global Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2034
  • Table 3: Global Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2034
  • Table 4: Global Bovine Vaccines Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2034
  • Table 6: North America Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2034
  • Table 7: North America Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2034
  • Table 8: North America Bovine Vaccines Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: Europe Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2034
  • Table 10: Europe Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2034
  • Table 11: Europe Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2034
  • Table 12: Europe Bovine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2034
  • Table 14: Asia Pacific Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2034
  • Table 15: Asia Pacific Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2034
  • Table 16: Asia Pacific Bovine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2034
  • Table 18: Latin America Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2034
  • Table 19: Latin America Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2034
  • Table 20: Latin America Bovine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2034
  • Table 22: Middle East & Africa Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2034
  • Table 23: Middle East & Africa Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2034
  • Table 24: Middle East & Africa Bovine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Bovine Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Bovine Vaccines Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Bovine Vaccines Market Value Share (%), by Route of Administration, 2025 & 2034
  • Figure 4: Global Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 5: Global Bovine Vaccines Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Bovine Vaccines Market Value (USD billion), by Product, 2025 & 2034
  • Figure 7: North America Bovine Vaccines Market Value Share (%), by Product, 2025
  • Figure 8: North America Bovine Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 9: North America Bovine Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 10: North America Bovine Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 11: North America Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 12: North America Bovine Vaccines Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Bovine Vaccines Market Value Share (%), By Country, 2025
  • Figure 14: Europe Bovine Vaccines Market Value (USD billion), by Product, 2025 & 2034
  • Figure 15: Europe Bovine Vaccines Market Value Share (%), by Product, 2025
  • Figure 16: Europe Bovine Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 17: Europe Bovine Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 18: Europe Bovine Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 19: Europe Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 20: Europe Bovine Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Bovine Vaccines Market Value (USD billion), by Product, 2025 & 2034
  • Figure 23: Asia Pacific Bovine Vaccines Market Value Share (%), by Product, 2025
  • Figure 24: Asia Pacific Bovine Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 25: Asia Pacific Bovine Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 26: Asia Pacific Bovine Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 27: Asia Pacific Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 28: Asia Pacific Bovine Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Bovine Vaccines Market Value (USD billion), by Product, 2025 & 2034
  • Figure 31: Latin America Bovine Vaccines Market Value Share (%), by Product, 2025
  • Figure 32: Latin America Bovine Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 33: Latin America Bovine Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 34: Latin America Bovine Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 35: Latin America Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 36: Latin America Bovine Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Bovine Vaccines Market Value (USD billion), by Product, 2025 & 2034
  • Figure 39: Middle East & Africa Bovine Vaccines Market Value Share (%), by Product, 2025
  • Figure 40: Middle East & Africa Bovine Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 41: Middle East & Africa Bovine Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 42: Middle East & Africa Bovine Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 43: Middle East & Africa Bovine Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 44: Middle East & Africa Bovine Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Bovine Vaccines Market Share (%), By Company, 2025